ERS Genomics and KU Leuven Sign CRISPR/Cas9 License Agreement to Expand CRISPR-Enabled Research Services
Agreement gives KU Leuven's Leuven Viral Vector Core access to foundational CRISPR/Cas9 intellectual property, supporting genome editing services for academic and industry researchers worldwide DUBLIN, and LEUVEN, Belgium, Oct. 22, 2026 /PRNewswire/ -- ERS Genomics Limited ('ERS...
Extrait seulement — cet éditeur protège son texte. Lisez le communiqué complet à la source.
Forfait Gratuit · Plus 29 $ CA ou Pro 99 $ CA/mois


